KDM1A and acute myeloid leukemia: All-trans retinoic acid, which induces the differentiation of acute myeloid leukemia and is used in leukemia treatment, has been studied in combination with several epigenetic regulators, including inhibitors of HDAC and LSD1 [42, 43].